Idioma:

Leukemic Stem Cells: A Review

O'Brien, J. A. ; Rizzieri, D. A.

Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Leukemic Stem Cells: A Review
Autor: O'Brien, J. A. ; Rizzieri, D. A.
Assuntos: Animals ; Antineoplastic agents ; Biological and medical sciences ; Hematologic and hematopoietic diseases ; Hematopoietic Stem Cells - pathology ; Humans ; Keywords: Leukemia ; Leukemia - pathology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Leukemic stem cells ; Medical sciences ; Neoplastic Stem Cells - pathology ; Pharmacology. Drug treatments ; Stem cell therapy
É parte de: Cancer investigation, 2013-05, Vol.31 (4), p.215-220
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Descrição: A small subset of cells in a patient with leukemia, termed leukemic stem cells (LSCs) have been shown to be responsible for the proliferation of disease. LSCs are thought to derive from normal hematopoietic stem cells, but are phenotypically distinguishable in that they are CD90-, CD117-, and CD123+. Research in mouse models provides several potential therapeutics to target these cells in human patients. Eliminating LSCs should provide an efficient, potentially curative treatment option for leukemia patients.
Editor: New York, NY: Informa Healthcare
Idioma: Inglês

Links

Voltar para lista de resultados